ENDRA LIFE SCIENCES INC. Restricted Stock or Unit Expense
ENDRA LIFE SCIENCES INC. (NDRA) reported Restricted Stock or Unit Expense of $114.31 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. restricted stock or unit expense for the quarter ending 2026-06-30 was $114.31K.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month |
|---|---|---|
| 2026-06-30 | $114.31K 10-Q · filed 2026-08-14 | $373.29K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |